Apolipoprotein-mediated pathways of lipid antigen presentation
Peter van den Elzen(Brigham and Women's Hospital), Michael B. Brenner(Brigham and Women's Hospital), D. Branch Moody(Brigham and Women's Hospital), Petr A. Illarionov(University of Birmingham), Frank M. Sacks(Harvard University), Elizabeth A. Leadbetter(Trudeau Institute), Sally C. Kent(University of Massachusetts Chan Medical School), Tan‐Yun Cheng(University of Notre Dame), Chris C. Dascher(Harvard University), Salil Garg(Harvard University), Jenny E. Gumperz(University of Wisconsin–Madison), Manfred Brigl(Brigham and Women's Hospital), Luis León(Harvard University), Gurdyal S. Besra(University of Birmingham)
Cited by 372
Related Papers
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
|Circulation|2013|2.3k
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
|New England Journal of Medicine|1991|1.2k
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
|Journal of the American College of Cardiology|2013|1.2k